How Far Is Too Far? The Ethics of Mini Brain Research
December 11, 2025
Brand Name :
Visine, tyzine
Synonyms :
tetrahydrozoline nasal
Class :
Drugs for asthma and COPD & Decongestant (Alpha-Adrenergic Agonist)
Dosage Forms & Strengths
Nasal Solution, Spray:
0.1% (10 ml, 15ml)
0.05%
Nasal congestion (Intranasal Spray):
2 to 4 drops or 3 to 4 sprays per nostril every 3 to 4 hrs or as needed (do not use more frequently than every 3 hrs)
Dosage Forms & Strengths
Nasal Solution, Spray:
0.1% (10 ml, 15ml)
0.05%
Note: for children,>6 years refer to adult dosing
Nasal congestion (Intranasal Spray):
2 to 4 drops (0.05% solution) per nostril every 4 to 6 hrs or as needed (do not use more frequently than every 3 hrs
Refer to adult dosing
may increase the hypertension effect
may have an increased hypertensive effect when combined with sympathomimetics
It may increase the hypertensive effect when combined with Sympathomimetics
methacholine: they may increase the hypertensive effect of sympathomimetics
it increases the toxicity of sympathomimetics
may increase the vasoconstriction effect
may increase the vasoconstriction effect
may increase the vasoconstriction effect
may increase the vasoconstriction effect
may increase the vasoconstriction effect
may increase the hypertension effect
may have an increasingly adverse effect when combined with sympathomimetics
aclidinium: they may increase the hypertensive effect of sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
may have an increasingly adverse effect when combined with other sympathomimetics
may have an increasingly adverse effect when combined with other sympathomimetics
may have an increasingly adverse effect when combined with other sympathomimetics
may have an increasingly adverse effect when combined with other sympathomimetics
may have an increasingly adverse effect when combined with other sympathomimetics
may enhance the tachycardic effect
may enhance the tachycardic effect
sympathomimetics: they may increase the hypertensive effect of Alpha 2-Agonists
sympathomimetics: they may increase the hypertensive effect of Alpha 2-Agonists
sympathomimetics: they may increase the hypertensive effect of Alpha 2-Agonists
sympathomimetics: they may increase the hypertensive effect of Alpha 2-Agonists
sympathomimetics: they may increase the hypertensive effect of Alpha 2-Agonists
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
they increase the toxicity of other sympathomimetics
sympathomimetics increase the effect of hypertension of solriamfetol
it increases the effect of hypertension of sympathomimetics
it increases the arrhythmogenic effect of sympathomimetics
sympathomimetics increase the toxicity of doxofylline
it increases the effect of hypertension of sympathomimetics
may increase the hypertension effect
may increase the therapeutic effect
may enhance the adverse/toxic effect of sympathomimetics
may increase the tachycardic effect of cannabinoid-containing products
may increase the toxic effect of sympathomimetics
may increase the toxic effect of sympathomimetics
may increase the toxic effect of sympathomimetics
may have an increased hypertensive effect when combined with sympathomimetics
may have an increased tachycardic effect when combined with sympathomimetics
may have an increased tachycardic effect when combined with sympathomimetics
may have an increasingly adverse effect when combined with doxofylline
may have an increased arrhythmogenic effect when combined with sympathomimetics
may have an increasingly adverse effect when combined with sympathomimetics
may have an increased hypertensive effect when combined with sympathomimetics
may have an increased hypertensive effect when combined with solriamfetol
may have an increasingly adverse effect when combined with other sympathomimetics
may have an increasingly adverse effect when combined with other sympathomimetics
may have an increasingly adverse effect when combined with other sympathomimetics
may have an increasingly adverse effect when combined with other sympathomimetics
may have an increasingly adverse effect when combined with other sympathomimetics
may have an increased hypertensive effect when combined with sympathomimetics
may increase the adverse effect of each other when combined
may enhance the risk of adverse effects
may enhance the risk of adverse effects
may enhance the risk of adverse effects
may enhance the risk of adverse effects
May increase the adverse effect when combined
may enhance the serum concentration when combined
esketamine: they may increase the arrhythmogenic effect of sympathomimetics
pergolide: they may increase the hypertensive effect of sympathomimetics
piribedil: they may increase the hypertensive effect of sympathomimetics
trimeprazine: they may increase the hypertensive effect of sympathomimetics
valerian: they may increase the hypertensive effect of sympathomimetics
secretin: they may increase the hypertensive effect of sympathomimetics
aldesleukin: they may increase the hypertensive effect of sympathomimetics
cimetropium: they may increase the hypertensive effect of sympathomimetics
desmopressin: they may increase the hypertensive effect of sympathomimetics
eluxadoline: they may increase the hypertensive effect of sympathomimetics
levosulpiride: they may increase the hypertensive effect of sympathomimetics
oxatomide: they may increase the hypertensive effect of sympathomimetics
revefenacin: they may increase the hypertensive effect of sympathomimetics
tiotropium: they may increase the hypertensive effect of sympathomimetics
amantadine: they may increase the hypertensive effect of sympathomimetics
mometasone furoate: they may increase the hypertensive effect of sympathomimetics
itopride: they may increase the hypertensive effect of sympathomimetics
mirabegron: they may increase the hypertensive effect of sympathomimetics
nitroglycerin: they may increase the hypertensive effect of sympathomimetics
tobacco: they may increase the hypertensive effect of sympathomimetics
topiramate: they may increase the hypertensive effect of sympathomimetics
theophylline: they may increase the hypertensive effect of sympathomimetics
cosyntropin: they may increase the hypertensive effect of sympathomimetics
dapsone: they may increase the hypertensive effect of sympathomimetics
it increases the effect of hypertension of sympathomimetics
it increases the effect of hypertension of sympathomimetics
they increase the efficacy of sympathomimetic drugs
they increase the efficacy of sympathomimetic drugs
they increase the efficacy of sympathomimetic drugs
they increase the efficacy of sympathomimetic drugs
they increase the efficacy of sympathomimetic drugs
Frequency defined:
>10%
Headache
1% to 10%
Dizziness
Nausea
Pain
Back pain
Myalgia
Weakness
Fever
<1%
Edema
Arthralgia
Bruise
Hepatitis
Hepatic failure
Insomnia
Pregnancy consideration: The drug may fall into the pregnancy category N.
Lactation: Tetrahydrozoline excretion in breast milk is not known.
Pregnancy category:
Patient information leaflet
Generic Name: tetrahydrozoline nasal
Pronounced: tetra-hydro-zolin
Why do we use tetrahydrozoline nasal?
tetrahydrozoline nasal is a Nasal decongestant. It relieves nasal blockage and congestion.